Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MMP12 | P39900 | 1/20 | 0.41 |
| ▸ | MMP13 | P45452 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.41 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.40 |
| ▸ | NPC1 | O15118 | 3/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | TNKS | O95271 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | GABRP | O00591 | 1/20 | 0.40 |
| ▸ | GABRD | O14764 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17720666 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL14295470 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL17720607 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL6374352 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL17720640 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL17637199 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL24255500 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL21128843 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL22355408 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD | |
| SCHEMBL14295471 | 1.00 | AHR (0.47) | AHRMAPTMEN1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11502257-B2 | Organic electroluminescence device and amine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2022-11-15 | — | — | US | disclosed |
| US-11038111-B2 | Organic electroluminescence device and monoamine compound for organic electroluminescence device | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-06-15 | — | — | US | disclosed |
| US-20200127208-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND AMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-04-23 | — | — | US | disclosed |
| US-20190165273-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-05-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11038111-B2 | Organic electroluminescence device and monoamine compound for organic electroluminescence device | MAOA, MAOB, AOC2 | AHR 912/4885MAPT 1313/4885MEN1 1141/4885 |
| US-20190165273-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND MONOAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | MAOA, MAOB, AOC2 | AHR 912/4885MAPT 1313/4885MEN1 1141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.